We have  expertise on RGD integrin drug discovery with an extensive publication track record.

We have experience in:

  • Delivering small molecule RGD integrin inhibitors of clinical quality
  • Experience of different modes of delivery (oral, iv, inhaled, long acting parenteral)
  • Expert knowledge of available integrin tools, probes for biological studies and screening assays
  • Application to the treatment of fibrotic diseases and cancer
  • Up-to-date competitor knowledge and patents